What services are eligible for reimbursement? (uninsured)

For dates of service or admittance on or after February 4, 2020 (aligning with Medicare coverage of COVID-19 services), reimbursement is made for qualifying testing for COVID-19, treatment services with a primary COVID-19 diagnosis, or for qualifying COVID-19 vaccine administration, as determined by HRSA (subject to adjustment as may be necessary), including the following:

• Specimen collection, diagnostic and antibody testing.
• Testing-related visits including in the following settings: office, urgent care or emergency room or telehealth.
• Treatment, including office visit (including telehealth), urgent care, emergency room, inpatient, outpatient/observation, skilled nursing facility, long-term acute care (LTAC), acute inpatient rehab, home health, DME (e.g., oxygen, ventilator), emergency ambulance transportation, non-emergent patient transfers via ambulance, and FDA-licensed, authorized, or approved treatments as they become available for COVID-19 treatment.
• Dispensing fees for FDA-licensed or authorized outpatient antiviral drugs for treatment of COVID-19.
• Administration fees related to FDA-authorized or licensed vaccines.

Claims are subject to Medicare timely filing requirements.